SUBSCRIBE
SUBSCRIBE

CNS Pharmaceuticals, Inc.

NEWS
Image of Houston downtown park and skyline in the morning
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.
March 13, 2025
 · 
6 min read
 · 
Angela Gabriel
IN THE PRESS
Lone Star Bio
CNS Pharmaceuticals to Present at the Virtual Investor Roundtable Event
November 16, 2021
 · 
2 min read
Lone Star Bio
CNS Pharmaceuticals Doses First Group of Patients with Berubicin, an FDA-Designated Fast Track Drug Candidate, in the Potentially Pivotal Study for the Treatment of Glioblastoma Multiforme (GBM)
September 30, 2021
 · 
8 min read
Business
CNS Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Outlook
August 13, 2021
 · 
7 min read
FDA
FDA Grants Fast Track Designation to CNS Pharmaceuticals for Berubicin for the Treatment of Recurrent Glioblastoma Multiforme
June 29, 2021
 · 
3 min read
Lone Star Bio
CNS Pharmaceuticals Announces Inclusion in the Russell 2000® Index
June 17, 2021
 · 
2 min read
Lone Star Bio
CNS Pharmaceuticals Commences Patient Enrollment in Potentially Pivotal Study of Berubicin
May 19, 2021
 · 
5 min read
Business
CNS Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Outlook
May 14, 2021
 · 
6 min read
Lone Star Bio
CNS Pharmaceuticals to Present at the Q2 Virtual Investor Summit
May 11, 2021
 · 
2 min read
Business
CNS Pharmaceuticals to Participate in Inaugural Emerging Growth Virtual Conference
March 15, 2021
 · 
3 min read
Lone Star Bio
CNS Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference
March 4, 2021
 · 
2 min read
Load More
JOBS